BetterLife Pharma
Financial ratios & Valuation

Historical Multiples (2015 – 2024)

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 TTM Median
Valuation Ratios
Price/Earnings ratio
-0.73-8.13-1.28-1.32K-2.26-1.08-1.14-1.28-1.41-2.84-0.50-2.26
Price/Sales ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Price/Book Value ratio
-10.62-212.12-5.48-3.54K5.968.01-9.03-4.02-1.19-0.76-0.628.01
Price/Cash Flow ratio
-14.00-425.67-21.40-407.14-4.20-2.70-5.81-1.39-8.50-3.32-1.95-4.20
Price/Free Cash Flow ratio
-14.00-425.67-21.40-407.14-3.59-2.52-5.73-1.39-8.50-3.32-1.95-3.59
Price/Earnings Growth ratio
-0.00-0.100.0413.52-0.00-0.04-0.370.010.030.03-0.00-0.04
Dividend Yield
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Operating Profit Margin
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Pretax Profit Margin
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Net Profit Margin
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Effective Tax Rate
-22.41%N/A1.80%-15.37%1.73%-2.43%0.00%-1.38%2.89%N/AN/AN/A
Return on Assets
-62269.06%-8084.10%-4732.63%-31.57%-107.66%-237.41%-2720.00%-1046.97%-12065.51%-889.62%-4559.29%-237.41%
Return On Equity
1443.67%2607.51%425.83%267.02%-263.69%-737.37%788.13%313.31%84.04%26.72%181.57%-263.69%
Return on Capital Employed
188.37%2611.90%408.57%2311.99%-191.74%-256.91%175.48%342.33%133.76%49.83%183.87%-191.74%
Liquidity Ratios
Current Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A0.04N/A
Quick Ratio
0.010.230.080.340.043.620.220.270.010.040.013.62
Cash ratio
0.010.160.060.150.012.790.020.040.000.000.002.79
Days of Sales Outstanding
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Days of Inventory outstanding
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Operating Cycle
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Days of Payables Outstanding
N/A485.84KN/A3.01K204.723.78M72.06M66.15K77.96KN/AN/A3.78M
Cash Conversion Cycle
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Debt Ratios
Debt Ratio
N/AN/A2.070.520.40N/A0.370.9715.881.0024.710.40
Debt Equity Ratio
N/AN/A-0.18-4.410.99N/A-0.10-0.29-0.11-0.03-0.66N/A
Long-term Debt to Capitalization
N/AN/AN/AN/AN/AN/AN/A-0.30-0.04-0.03-0.05N/A
Total Debt to Capitalization
N/AN/A-0.221.290.49N/A-0.12-0.41-0.12-0.03-0.13N/A
Interest Coverage Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A-159.92N/A
Cash Flow to Debt Ratio
N/AN/A-1.37-1.97-1.43N/A-14.32-9.85-1.26-7.54-2.59N/A
Company Equity Multiplier
-0.02-0.32-0.08-8.452.443.10-0.28-0.29-0.00-0.03-0.023.10
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Free Cash Flow / Operating Cash Flow Ratio
11111.171.061.0111111.06
Cash Flow Coverage Ratio
N/AN/A-1.37-1.97-1.43N/A-14.32-9.85-1.26-7.54-2.59N/A
Short Term Coverage Ratio
N/AN/A-1.37-1.97-1.43N/A-14.32-47.09-2.01N/A-4.68N/A
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A